---

Staphylococcus aureus - A Detailed Mechanistic Account

Note: Apurba Sastry's "Essentials of Medical Microbiology" is not available in the current textbook library. The primary reference below is Jawetz's Medical Microbiology 9e, supplemented with Sherris & Ryan's Medical Microbiology (8th ed), both of which align with Apurba Sastry's coverage on this topic.

---

1. Nomenclature and Basic Identity

---

2. Morphology and Staining

• Gram-positive cocci, 0.5-1.5 µm in diameter
• Arranged in grape-like clusters (the classic textbook description) - but in clinical specimens, they often appear as single cells, pairs, or short chains
• Why clusters? Division occurs in multiple planes (unlike streptococci which divide in one plane forming chains). Cells remain attached after division due to incomplete separation, creating the cluster pattern.
• Non-motile, non-spore forming, usually non-capsulate (though some strains produce a microcapsule)

• It is the reason organisms can survive on dry surfaces for long periods - unlike gram-negatives that lack this thick layer and outer membrane protection
• The peptidoglycan triggers host complement activation and inflammation
• It provides structural rigidity allowing survival in high salt (10% NaCl) - hence S. aureus grows on mannitol salt agar, a selective medium

---

3. Cultural Characteristics

---

4. Virulence Factors - The Core of Pathogenicity

A. Structural Virulence Factors

1. Protein A

• Located in the cell wall
• Binds the Fc region of IgG antibodies (specifically IgG1, IgG2, IgG4 in humans) backwards (Fc end instead of Fab end)
• Why this is clever: Normally, antibodies coat bacteria (opsonization), with the Fc end pointing outward to be recognized by neutrophil Fc receptors. Protein A reverses this - it mops up IgG by binding Fc portions, leaving no Fc region exposed for phagocyte recognition. The result: opsonization is blocked and phagocytosis is impaired.
• Also activates complement via the alternative pathway, contributing to inflammation
• Useful diagnostically: Protein A binds IgG on latex beads - basis of latex agglutination tests

2. Coagulase

• The defining virulence factor that distinguishes S. aureus from all other staphylococci
• Two forms:
  • Free coagulase (secreted into medium) - detected by tube coagulase test
  • Bound coagulase (clumping factor, cell wall bound) - detected by slide coagulase test
• Mechanism: Coagulase binds a plasma protein called Coagulase-Reacting Factor (CRF), which is actually prothrombin. This Coagulase-CRF complex (Staphylothrombin) converts fibrinogen → fibrin
• Why coagulase is a virulence factor: It creates a fibrin coat around the bacterium, essentially disguising it in host protein. This fibrin barrier:
  • Prevents phagocytosis
  • Protects against antibody binding
  • Walls off abscesses (the hallmark of staphylococcal infection) - the abscess capsule is largely this fibrin mesh
  • This explains why S. aureus infections classically produce pus-filled abscesses rather than spreading cellulitis

3. Capsular Polysaccharide (Microcapsule)

• Most clinical strains of S. aureus produce a polysaccharide microcapsule (especially serotypes 5 and 8, which account for >75% of clinical isolates)
• Function: Anti-phagocytic - masks surface molecules from complement deposition and phagocyte recognition
• Paradox: Some strains are acapsulate, yet still virulent - other mechanisms compensate

4. Peptidoglycan and Teichoic Acids

• Peptidoglycan: Activates complement (alternative pathway) and stimulates inflammatory cytokines (IL-1, IL-6, TNF). This drives the inflammatory response in infections.
• Teichoic acids: Mediate adherence to host epithelial cells (especially fibronectin-binding); also act as a signal for peptidoglycan hydrolase (autolysin) activity during cell division

5. Surface Adhesins - MSCRAMMs

• These are cell-wall-anchored proteins that bind host extracellular matrix proteins
• Fibronectin-binding proteins (FnBPs): Allow adhesion to fibronectin coating catheters and damaged endothelial surfaces → reason S. aureus is the most common cause of catheter-related bacteremia and infective endocarditis
• Collagen-binding protein (Cna): Mediates adherence to cartilage and bone → explains osteomyelitis and septic arthritis
• Fibrinogen-binding proteins / Clumping factor (ClfA, ClfB): Bind fibrinogen on platelet-fibrin thrombi on damaged heart valves → endocarditis pathogenesis
• Elastin-binding protein (EbpS): Important in lung infections

6. Polysaccharide Intercellular Adhesin (PIA) / Biofilm

• Allows formation of biofilm on prosthetic devices, catheters, implants
• Within biofilm, bacteria are protected from antibiotics and immune cells
• Explains why prosthetic device infections are notoriously difficult to treat and often require device removal

---

B. Secreted Enzymes

1. Catalase

• Converts H₂O₂ → H₂O + O₂
• Why: Neutrophils kill bacteria using a "respiratory burst" generating H₂O₂. Catalase neutralizes this weapon directly. All staphylococci are catalase-positive (this is what differentiates them from streptococci, which are catalase-negative).

2. Hyaluronidase ("Spreading Factor")

• Degrades hyaluronic acid in connective tissue ground substance
• Why: Breaks down the "cement" between cells, facilitating the spread of infection through tissue planes. Hence the name "spreading factor."

3. Fibrinolysin (Staphylokinase)

• Activates plasminogen → plasmin, which dissolves fibrin clots
• Why the contradiction with coagulase? Coagulase walls off the initial abscess (early in infection, protective for the bacterium). Once established, staphylokinase dissolves the fibrin, allowing spread to new sites. It is a sequential "clot to spread" strategy.

4. Lipases and Proteases

• Degrade lipids and proteins in sebum and tissue
• Facilitate invasion through skin and subcutaneous tissue
• Explain predilection for hair follicles (rich in sebum) → folliculitis, furuncles

5. Beta-lactamase (Penicillinase)

• Hydrolyzes the beta-lactam ring of penicillins
• Acquired via plasmid transfer (R-factor) - explains how antibiotic resistance spread rapidly after penicillin was introduced in the 1940s
• Over 90% of S. aureus strains now produce beta-lactamase, making standard penicillin ineffective

---

C. Toxins (The Major Pathology-Producers)

1. Alpha-Toxin (Alpha-Hemolysin)

• The major cytotoxin of S. aureus
• Forms heptameric beta-barrel pores in cell membranes (binds ADAM10 receptor on cell surface as a monomer, oligomerizes to form the pore)
• Why pore-forming matters: The pore disrupts ion gradients → osmotic lysis of cells. Targets include: RBCs (hemolysis - the beta-hemolysis on blood agar), platelets, leukocytes, endothelial cells, smooth muscle cells
• Explains: Tissue necrosis, dermonecrosis, vascular injury, and destruction of platelet function leading to bleeding tendency in severe infections

2. Beta-Toxin (Sphingomyelinase C)

• Cleaves sphingomyelin (a phospholipid) from cell membranes
• Hot-cold phenomenon: Most active at 37°C, but hemolysis appears on cooling to 4°C (due to clustering of sphingomyelin fragments after enzymatic cleavage)

3. Delta-Toxin

• Surfactant-like molecule, disrupts membranes non-specifically
• Has a role in inflammatory skin diseases including atopic dermatitis (chronic S. aureus colonization triggers delta-toxin mediated mast cell degranulation)

4. Panton-Valentine Leukocidin (PVL)

• Bi-component toxin (LukS-PV + LukF-PV, two separate secreted proteins that assemble on cell surface)
• Targets and lyses neutrophils and macrophages specifically (binds C5aR and C5L2 on neutrophils)
• Why this is catastrophic: It depletes the host's primary cellular defense. The neutrophil is the first responder to bacterial infection; PVL eliminates it.
• Strongly associated with community-acquired MRSA (CA-MRSA) strains
• Clinical relevance: Responsible for severe necrotizing pneumonia (rapidly progressive, hemorrhagic, frequently fatal in young, previously healthy individuals), recurrent deep-seated furunculosis, and necrotizing fasciitis
• The necrosis is not just from direct tissue damage but from the massive neutrophil death releasing their toxic contents (DNases, proteases, elastases) into surrounding tissue

5. Exfoliative Toxins (ETs) - Epidermolytic Toxins

• Both are serine proteases that specifically cleave desmoglein-1, a cadherin-type cell-cell adhesion molecule in the superficial epidermis (stratum granulosum)
• Why the blistering? Desmoglein-1 is the molecular "rivet" holding keratinocytes together in the epidermis. When cleaved, the intercellular bonds break → the superficial epidermis separates from deeper layers → large fluid-filled bullae form.
• This produces Staphylococcal Scalded Skin Syndrome (SSSS) also called Ritter's disease in neonates
• In adults: ETs cause Bullous impetigo (localized) or full SSSS (disseminated)
• Nikolsky sign: Gentle lateral pressure on skin causes epidermis to slide off - because desmoglein-1 has been destroyed, there is no adhesion holding the stratum granulosum in place
• Crucially, the bacteria may be far away - SSSS can be caused by a localized infection (like conjunctivitis or umbilical stump infection in a neonate) because the exfoliatin is absorbed systemically and acts remotely on the skin. This is analogous to how Clostridium botulinum produces neurotoxin at one site but effects manifest throughout the body.
• Why neonates are most susceptible: Desmoglein-1 is most highly expressed in the superficial epidermis of neonates; also, neonatal kidneys lack full filtration capacity and cannot rapidly clear the circulating toxin.

6. Toxic Shock Syndrome Toxin-1 (TSST-1)

• Previously called Pyrogenic exotoxin C or Staphylococcal enterotoxin F
• A superantigen - the most important concept for understanding TSS
• Normal T-cell activation: An antigen-presenting cell (APC) displays a specific antigen peptide via MHC class II to a T-cell receptor (TCR) that specifically recognizes it. Only ~0.01% of T cells respond to any given antigen.
• Superantigen mechanism: TSST-1 bypasses the antigen-specific binding. It cross-links MHC class II molecules (on APCs) with the Vβ region (the variable beta chain) of TCRs directly, non-specifically. This activates ALL T cells bearing a particular Vβ type - up to 20-30% of all T cells simultaneously (vs. 0.01% in normal response).
• This mass T-cell activation results in massive, uncontrolled release of cytokines (IL-1, IL-2, TNF-α, IFN-γ) - a cytokine storm
• The cytokine storm is responsible for all clinical features of TSS:
  • Fever (IL-1, TNF-α are endogenous pyrogens)
  • Hypotension/Shock (TNF-α causes vasodilation and increased vascular permeability)
  • Multi-organ failure (cytokine-mediated endothelial injury)
  • Diffuse erythematous rash (cytokine-mediated capillary leak in skin)
  • Desquamation (1-2 weeks later, particularly on palms and soles)
• Classic scenario: Menstrual TSS - hyperabsorbent tampons left in place provide both a protein-rich growth medium and allow vaginal mucosal microabrasions (portal of entry). The problem is not the bacteria getting into blood - it is the toxin being absorbed.
• Non-menstrual TSS: Any S. aureus wound infection (post-surgical, nasal packing, burns) can release TSST-1

7. Staphylococcal Enterotoxins (A through E, G through J, and more)

• Approximately 20 serotypes described (SEA, SEB, SEC, SED, SEE are most classic; SEA is most common cause of food poisoning)
• Also superantigens (like TSST-1) but the mechanism of food poisoning is different
• They are heat-stable (withstand 100°C for 30 minutes) - this is a critical food safety concept. Cooking kills the bacteria but does NOT destroy the toxin. Reheating contaminated food will not make it safe.
• They are also resistant to gastric acid and intestinal proteases, allowing them to remain active in the gut
• Mechanism of food poisoning: They stimulate the vagal afferent nerves in the gut, which transmit signals to the emetic center in the medulla → violent vomiting (not primarily diarrhea). They also directly stimulate gut motility (diarrhea).
• Why rapid onset (1-6 hours)? It is intoxication (pre-formed toxin ingested), not infection (bacteria colonizing gut). No incubation period for bacterial growth needed.
• Why short duration (8-24 hours)? Once the toxin is cleared from the gut, symptoms resolve. No ongoing bacterial infection.
• Common vehicles: Ham, custard pastries, potato salad, ice cream, salted meats (organisms grow in salt, contaminants from food handlers)

---

5. Epidemiology - With Reasoning

Carriage Sites

• Anterior nares (nostrils): The primary reservoir. ~20-30% of adults are persistent carriers; ~60% intermittent carriers.
• Why the anterior nares? The environment is rich in fibronectin (on nasal epithelial cells), which S. aureus adhesins (FnBPs) bind avidly. The moist, warm, protein-rich environment supports colonization.
• Other sites: Skin, axillae, perineum, pharynx

Transmission

• Person-to-person: Direct contact, nasal discharge, infected skin lesions
• Fomites: Contaminated bed linens, clothing, hospital surfaces
• Why survives on surfaces so long? Thick peptidoglycan wall + absence of outer membrane (unlike gram-negatives) = much greater resistance to desiccation

At-Risk Groups

• Neonates: For SSSS (high desmoglein-1 expression, immature immunity, immature renal clearance)
• Young children with poor hygiene: Impetigo, furuncles (skin trauma + S. aureus colonization)
• IV drug users: Bacteremia, right-sided endocarditis (bacteremia from injection directly into bloodstream)
• Patients with intravascular catheters/prosthetic devices: Biofilm formation on foreign bodies; fibronectin coating on catheters is a landing pad for FnBPs
• Post-influenza patients: Influenza virus destroys respiratory epithelium, removing the mucociliary clearance defense. S. aureus settles in the denuded airways → secondary bacterial pneumonia. This is why severe influenza seasons see spikes in staphylococcal pneumonia deaths.
• Patients with eczema/atopic dermatitis: Disrupted skin barrier, reduced defensin expression → >90% colonized with S. aureus

---

6. Diseases - A Systematic Account

A. Toxin-Mediated Diseases (bacteria not at site of disease)

B. Pyogenic (Suppurative) Infections

• Folliculitis: Superficial infection of hair follicle. S. aureus colonizes sebaceous gland openings; lipases degrade sebum, gaining entry.
• Furuncle (Boil): Deeper infection of hair follicle and surrounding tissue. The abscess develops due to coagulase activity creating fibrin walls.
• Carbuncle: Coalescence of multiple furuncles with multiple draining sinuses. Most common on posterior neck. Requires drainage + antibiotics.
• Impetigo: Superficial skin infection. Two forms: Non-bullous impetigo (mixed S. aureus and Streptococcus pyogenes) and Bullous impetigo (pure S. aureus, ETs involved)
• Wound Infections: Post-surgical; organisms from nasal carriage of surgical staff or patient's own flora
• Mastitis: Infection of lactating breast via cracked nipple; S. aureus from infant's nasal flora

C. Deep/Systemic Infections

Bacteremia and Sepsis

• Source: Skin infections, IV catheters, endocarditis
• Consequences: Seeding of virtually any organ
• The presence of bacteremia should always prompt consideration of endocarditis

Infective Endocarditis

• S. aureus is the #1 cause of acute endocarditis on native valves (especially in IV drug users, typically tricuspid valve)
• Pathogenesis: FnBPs and ClfA bind fibronectin/fibrinogen on damaged valve surfaces or platelet-fibrin thrombi → colonization → vegetation formation
• Produces acute, destructive endocarditis (rapidly destroying valve leaflets) in contrast to the subacute form caused by viridans streptococci
• High rate of embolic complications (vegetation fragments embolize → stroke, renal infarcts, splenic infarcts, Janeway lesions, Osler's nodes)

Pneumonia

• Mechanisms: Hematogenous seeding from bacteremia OR direct inhalation (post-viral)
• Produces necrotizing pneumonia particularly if PVL-producing strain (CA-MRSA)
• Radiologically: Cavitary lesions, pneumatoceles (thin-walled air-filled cavities, particularly in children)

Osteomyelitis

• Most common cause of hematogenous osteomyelitis in children (long bone metaphysis)
• Why the metaphysis? The metaphysis of growing bones has sluggish capillary loops with few phagocytic cells - bacteria lodged here are relatively protected. Additionally, sinusoidal capillaries lack phagocytic lining cells.
• Collagen-binding protein (Cna) mediates adherence to bone matrix
• In adults, vertebral osteomyelitis is more common

Septic Arthritis

• Via hematogenous seeding or direct inoculation
• Large weight-bearing joints in children; prosthetic joint infections in elderly
• Bacterial enzymes and toxins destroy cartilage

Meningitis

• Less common than from gram-negatives; usually via hematogenous seeding or direct spread from CSF shunts/neurosurgery

---

7. Antibiotic Resistance - MRSA

The Beta-Lactam Mechanism (Why MRSA Exists)

• In MSSA (Methicillin-Sensitive S. aureus): Beta-lactamase destroys penicillin G/V; semi-synthetic penicillins (methicillin, nafcillin, oxacillin) were designed to be beta-lactamase resistant and remain effective.
• In MRSA: An entirely different mechanism. A mobile genetic element (SCCmec - Staphylococcal Cassette Chromosome mec) carries the mecA gene, which encodes an altered PBP called PBP2a (or PBP2'). PBP2a has a very low affinity for ALL beta-lactam antibiotics. So even if methicillin/oxacillin reaches the bacterial cell, it cannot bind PBP2a → cross-linking continues → cell wall synthesis continues → bacteria survive.

Two Types of MRSA

VRSA (Vancomycin-Resistant S. aureus)

• Extremely rare (only a few dozen reported cases worldwide)
• Mechanism: Acquired vanA gene from enterococci (via horizontal gene transfer/conjugation), which alters the peptidoglycan precursor terminus from D-Ala-D-Ala to D-Ala-D-Lac - vancomycin cannot bind the modified terminus

---

8. Laboratory Diagnosis - Reasoning

Gram Stain

• Shows gram-positive cocci in clusters
• Useful for pyogenic infections (pus, CSF in meningitis) but not for:
  • Bacteremia (too few organisms in blood to see on smear)
  • Toxin-mediated diseases (organisms may not be at disease site)

Culture

• Grows on non-selective media (blood agar) in 18-24 hours
• Blood agar: Beta-hemolysis (alpha-toxin mediated pore formation in RBCs)
• Mannitol Salt Agar (MSA): Selective for staphylococci (10% NaCl kills most bacteria); S. aureus ferments mannitol → yellow halo around colonies (differential)
• Chromogenic agar: Colors S. aureus colonies a distinct color (mauve/blue depending on brand) - based on chromogenic enzyme substrates that S. aureus cleaves; useful for MRSA screening

Coagulase Test (Definitive S. aureus ID)

• Slide test (Clumping factor): Bound coagulase - a loopful of colony + plasma on a glass slide; positive result = clumping in 5-10 seconds. Rapid screening test.
• Tube test (Free coagulase): Colony in plasma-containing tube incubated at 37°C; positive = clot formation in 1-4 hours. Confirmatory test.
• Sensitivity: Near 100% for S. aureus detection; rare coagulase-negative S. aureus strains exist

Molecular Methods

• PCR/NAAT: Detect mecA gene (confirms MRSA) and nuc gene (thermonuclease, specific for S. aureus)
• MALDI-TOF Mass Spectrometry: Identifies organisms by their unique protein mass spectrometric fingerprint - fast, accurate
• Phage typing: Traditional method; identifies the bacteriophage lytic pattern to epidemiologically type outbreak strains (largely replaced by molecular typing)

---

9. Treatment

Principle: Match Antibiotic to Resistance Profile

Why Vancomycin Works (and Fails)

• Mechanism: Binds the D-Ala-D-Ala terminal of lipid II (peptidoglycan precursor), sterically blocking transglycosylation and transpeptidation
• Resistance (in enterococci, rarely S. aureus): vanA gene converts D-Ala-D-Ala to D-Ala-D-Lac, reducing vancomycin binding by 1000-fold
• Vancomycin-Intermediate S. aureus (VISA): Not a single gene change but a phenotypic adaptation - the peptidoglycan wall becomes thickened with false D-Ala-D-Ala termini that trap and consume vancomycin before it reaches its true target. The organism "mops up" vancomycin in its outer cell wall layers.

Why Daptomycin Works

• Cyclic lipopeptide; inserts its lipid tail into the bacterial cell membrane in a calcium-dependent manner, forming a complex that disrupts the membrane potential (depolarization) → inhibits DNA, RNA, and protein synthesis → bactericidal. Not useful for pulmonary infections (inactivated by pulmonary surfactant).

---

10. Prevention and Control

• Hand hygiene: Most effective intervention. S. aureus transmitted by hands of healthcare workers.
• MRSA decolonization: Intranasal mupirocin (inhibits isoleucyl-tRNA synthetase, preventing bacterial protein synthesis) + chlorhexidine body wash. Used for high-risk pre-surgical patients.
• Decontamination of surfaces: Sporicidal/bactericidal cleaning. S. aureus survives on surfaces for weeks.
• Isolation: Contact precautions for MRSA-positive patients.
• Vaccine: No licensed human vaccine yet (multiple failed trials). Challenges include: capsular polysaccharide variability, immune evasion mechanisms, and the complexity of S. aureus virulence factor diversity.

---

Summary: The "Reason Behind" Each Property

---